A Multi-center, Randomized, Study to Compare the Effectiveness of Sirolimus-eluting Stent (Ultimaster Stent) or Everolimus-eluting Stent (XIience Alpine Stent) for Long Coronary Lesions
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms LONG-DES VII
- 01 Oct 2018 Status changed from not yet recruiting to recruiting.
- 25 Jun 2018 Planned initiation date changed from 30 Apr 2018 to 30 Aug 2018.
- 02 Apr 2018 New trial record